Physician profile
Ryan Rahhal
NPI 1932241742
$1,466.96
in general payments reported to CMS, 2019-2025
22 companies · $441 in 2025
The $441 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $205 · 2020: $39.74 · 2021: $65.14 · 2022: $210 · 2023: $213 · 2024: $292 · 2025: $441.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $947.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $946.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Providence Medical Technology, INC. | $228.77 | 2024-2025 | |
| Kuros Biosciences USA, INC | $187.76 | 2025 | Magnetos |
| Highridge Medical LLC | $166.11 | 2024 | Vital |
| Pfizer INC. | $104.04 | 2023-2025 | |
| Zimvie INC. | $72.28 | 2023 | |
| Aesculap, INC. | $62.94 | 2022 | |
| Globus Medical, INC. | $61.18 | 2021-2024 | Modulus |
| Baxter Healthcare | $59.91 | 2019-2022 | |
| Integra Lifesciences Corporation | $58.91 | 2019 | |
| Zimmer Biomet Holdings, INC. | $57.59 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $54.08 | 2023-2024 | Andexxa |
| Depuy Synthes Sales INC. | $53.61 | 2019 | |
| Augmedics INC. | $50.76 | 2023 | Xvision |
| Portola Pharmaceuticals, LLC | $44.52 | 2019 | |
| Kls-Martin L.P. | $39.74 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arteriocyte Medical Systems, INC. | $35.13 | 2022 | |
| Alphatec Spine, INC | $33.33 | 2019 | |
| Medtronic, INC. | $23.12 | 2024 | Catalyft Pl Expandable Interbody System |
| Si-Bone, INC. | $19.63 | 2022 | |
| Bioventus LLC | $19.53 | 2022 | |
| Stryker Corporation | $19.02 | 2023 | Na, Duramatrix, Universal Neuro 3 |
| Kowa Pharmaceuticals America, INC. | $15.00 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Rahhal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.